Search filters

List of works by Moshit Lindzen

A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways

scientific article published on 02 July 2018

A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy

A functional interaction between CHIF and Na-K-ATPase: implication for regulation by FXYD proteins

scientific article published on 01 October 2002

A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors.

scientific article published on 30 September 2016

A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration

scientific article

A specific functional interaction between CHIF and Na,K-ATPase: role of FXYD proteins in the cellular regulation of the pump

scientific article

AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

scientific article published on 07 February 2019

An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors

scientific article

Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy

scientific article published on April 2016

Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer

scientific article published on 2 June 2015

Covalent cross-links between the gamma subunit (FXYD2) and alpha and beta subunits of Na,K-ATPase: modeling the alpha-gamma interaction

scientific article published on 2 March 2005

Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination

scientific article published on 27 March 2017

Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment

scientific article

Domains involved in the interactions between FXYD and Na,K-ATPase

scientific article published on 01 April 2003

Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.

scientific article

Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone

scientific article published on 28 September 2017

Examination of HER3 targeting in cancer using monoclonal antibodies

scientific article

Functional interactions of phospholemman (PLM) (FXYD1) with Na+,K+-ATPase. Purification of alpha1/beta1/PLM complexes expressed in Pichia pastoris

scientific article published on 11 April 2006

Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.

scientific article published on 14 January 2013

Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors

scientific article published on 01 February 2022

SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.

scientific article

Structural interactions between FXYD proteins and Na+,K+-ATPase: alpha/beta/FXYD subunit stoichiometry and cross-linking

scientific journal article

Structure-function relations of interactions between Na,K-ATPase, the gamma subunit, and corticosteroid hormone-induced factor

scientific journal article

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer

scientific article published on 20 January 2015

Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands

scientific article

Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor

scientific article published on 24 August 2020

Paulina is supported by:

About Paulina

Help